Teva Pharmaceutical (002728.SZ) released its first quarter performance, with a net profit attributable to the parent company of 31.5673 million yuan, an increase of 244.82% year-on-year.

Chinatimes Financial News APP News, Teji Pharmaceutical (002728.SZ) released the first quarter report of 2025. In the first quarter, the company achieved operating income of 295 million yuan, a year-on-year increase of 79.29%. The net profit attributable to the shareholders of the listed company was 31.5673 million yuan, a year-on-year increase of 244.82%. The net profit attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 31.7069 million yuan, a year-on-year increase of 255.28%.